Journal Information

On this page: About the journal | Aims and scope of journal | Our publishing models | Impact Factor | Abstracted/indexed in | ISSN and eISSN | Newsfeeds

About the journal

Research on antibiotics and other microbial products is pivotal to the global battle against the growing problem of antibiotic resistance. As well as the traditional research and development model of finding replacement drugs to tackle this problem, there are other important new strategies for addressing resistance which include research into bioactive microbial products.

The Journal of Antibiotics forms an integral part of this battle against resistance by encouraging and publishing original research articles that report findings of wide biological significance in the multidisciplinary field of antimicrobials. We specifically encourage articles that represent important advances in the field of antimicrobial research, including recently discovered antibiotics, bioactive microbial products and novel strategies for combating antibiotic resistance. The Journal of Antibiotics provides a dynamic platform for communicating research on microbial products and antimicrobial approaches through also including insightful and up-to-date reviews, short communications and letters to the editor.

Aims and scope of journal

The Journal of Antibiotics seeks to promote research on antibiotics and related types of biologically active substances and publishes Articles, Review Articles, Brief Communication, Correspondence and other specially commissioned reports. The Journal of Antibiotics accepts papers on biochemical, chemical, microbiological and pharmacological studies. However, studies regarding human therapy do not fall under the journal’s scope. Contributions regarding recently discovered antibiotics and biologically active microbial products are particularly encouraged. Topics of particular interest within the journal's scope include, but are not limited to, those listed below:

  • Discovery of new antibiotics and related types of biologically active substances
  • Production, isolation, characterization, structural elucidation, chemical synthesis and derivatization, biological activities, mechanisms of action, and structure-activity relationships of antibiotics and related types of biologically active substances
  • Biosynthesis, bioconversion, taxonomy and genetic studies on producing microorganisms, as well as improvement of production of antibiotics and related types of biologically active substances
  • Novel physical, chemical, biochemical, microbiological or pharmacological methods for detection, assay, determination, structural elucidation and evaluation of antibiotics and related types of biologically active substances
  • Newly found properties, mechanisms of action and resistance-development of antibiotics and related types of biologically active substances

Our publishing models   

The Journal of Antibiotics is a Transformative Journal (TJ). When research is accepted for publication, authors can choose to publish using either the traditional publishing route OR via immediate gold Open Access. 

The Journal of Antibiotics is actively committed to becoming a fully Open Access journal. We will increase the number of articles we publish OA, with the eventual goal of becoming a fully Open Access journal. A journal that commits to this process is known as a Transformative Journal. 

Find out more about Transformative Journals

Authors may need to take specific actions to achieve compliance with funder and institutional open access mandates. If your research is supported by a funder that requires immediate open access (e.g. according to Plan S principles) then you should select the gold OA route, and we will direct you to the compliant route where possible. For authors selecting the subscription publication route our standard licensing terms will need to be accepted including our self-archiving policies. Those standard licensing terms will supersede any other terms that the author or any third party may assert apply to any version of the manuscript.

Impact factor

The 2020 journal citation metrics for The Journal of Antibiotics are as follows:

2-year Impact Factor*: 2.649
5-year Impact Factor*: 2.772
Immediacy index*: 1.07
Eigenfactor® score*: 0.00446
Article influence score*: 0.617
JCR Rank*: IMMUNOLOGY 129/162; PHARMACOLOGY & PHARMACY 185/275;MICROBIOLOGY 98/137; BIOTECHNOLOGY & APPLIED MICROBIOLOGY 103/159
Journal Citation Indicator*: 0.65

SNIP: 0.958
SJR: 0.56

*2020 Journal Citation Reports® Science Edition (Clarivate Analytics, 2021)

Speed

Submission to first decision (2020): 18 days
Submission to Acceptance (2020): 70 days
Acceptance to online publication (2020)­­­: 18 days

Usage

775,574 Downloads (in 2020)

Abstracted/indexed in

Medline
Current Contents/Life Sciences
Science Citation Index
Science Citation Index Expanded
Journal Citation Reports/Science Edition
BIOSIS Previews
Scopus
EBSCO Discovery Service
Google Scholar
OCLC
Summon by Proquest

 

ISSN and eISSN

The international standard serial number (ISSN) for The Journal of Antibiotics is 0021-8820, and the electronic international standard serial number (eISSN) is 1881-1469.

Newsfeeds

The Journal of Antibiotics now provides its latest table of contents as an RSS web  feed. This allows users with an RSS reader to receive automatic updates whenever new content is added to these pages.

Receive The Journal of Antibiotics's current issue table of contents.

Receive The Journal of Antibiotics's AOP table of contents.

Find out more about RSS feeds, how to download an RSS reader and see all the news feeds offered by Springer Nature.